University at Buffalo (UB)
Svetlana Primma Eckert
Svetlana Primma Eckert
Clinical Assistant Professor of Neurology
Jacobs School of Medicine & Biomedical Sciences
Specialty/Research Focus
General Neurology; Multiple Sclerosis; Neuroimaging; Neuroimaging Analysis; Neuroimmunology; Neurology
Contact Information
Patient Care
Patient Care
This faculty member is affiliated with UBMD, practicing physicians who are also professors in the Jacobs School.
View this physician on UBMDProfessional Summary:
Svetlana Eckert, M.D. joined the Department of Neurology at Jacobs School of Medicine and Biomedical Sciences, Univ. at Buffalo in July 2019. Dr. Eckert completed her neurology residency and fellowship training at University at Buffalo. She specializes in multiple sclerosis and neuroimaging and is caring for patients with various autoimmune and inflammatory neurologic disorders at UBMD Neurology practice sites downtown and in Williamsville.
Her areas of interest include neuromyelitis optica spectrum Disorder (NMOSD), neurosarcoidosis, and multiple sclerosis.
Education and Training:
- Fellowship, Multiple Sclerosis and Other Autoimmune Neurologic Disorders, UBMD Neurology - University at Buffalo (2019)
- Fellowship, Neuroimaging, UBMD Neurology - University at Buffalo (2019)
- MD, Medicine, University at Buffalo Jacobs School of Medicine and Biomedical Sciences (2013)
- Internship, NINDS Clinical Research, National Institute of Diabetes and Digestive and Kidney Disorders (NIH) (2009)
- BA, Biophysics, Johns Hopkins University - Krieger School of Arts and Sciences (2008)
Employment:
- Clinical Assistant Professor of Neurology, Neurology, UBMD Neurology Jacobs School of Medicine & Biomedical Sciences
Research Expertise:
- Multiple Sclerosis and other neurologic autoimmune diseases.: I am particularly interested in antibody-mediated neurologic diseases.
Journal Articles:
- Morrow SA, Conway D, Fuchs T, Wojcik C, Unverdi M, Yasin F, Pol J, Eckert S, Hojnacki DH, Dwyer M, Zivadinov R, Weinstock-Guttman B, Benedict RH. (2021) Quantifying cognition and fatigue to enhance the sensitivity of the EDSS during relapses. Multiple sclerosis (Houndmills, Basingstoke, England) (Jun), 27(7): 1077-1087.
- Jakimovski D, Eckert SP, Zivadinov R, Weinstock-Guttman B. (2021) Considering patient age when treating multiple sclerosis across the adult lifespan. Expert review of neurotherapeutics (Mar), 21(3): 353-364.
- Hildesheim FE, Ramasamy DP, Bergsland N, Jakimovski D, Dwyer MG, Hojnacki D, Lizarraga AA, Kolb C, Eckert S, Weinstock-Guttman B, Zivadinov R. (2021) Leptomeningeal, dura mater and meningeal vessel wall enhancements in multiple sclerosis. Multiple sclerosis and related disorders (Jan), 47: 102653.
- Benedict RH, Pol J, Yasin F, Hojnacki D, Kolb C, Eckert S, Tacca B, Drake A, Wojcik C, Morrow SA, Jakimovski D, Fuchs TA, Dwyer MG, Zivadinov R, Weinstock-Guttman B. (2021) Recovery of cognitive function after relapse in multiple sclerosis. Multiple sclerosis (Houndmills, Basingstoke, England) (Jan), 27(1): 71-78.
- Jakimovski D, Dujmic D, Hagemeier J, Ramasamy DP, Bergsland N, Dwyer MG, Eckert S, Kolb C, Lizarraga A, Hojnacki D, Weinstock-Guttman B, Zivadinov R. (2020) Late onset multiple sclerosis is associated with more severe ventricle expansion. Multiple sclerosis and related disorders (Nov), 46: 102588.
- Ghione E, Bergsland N, Dwyer MG, Hagemeier J, Jakimovski D, Ramasamy DP, Hojnacki D, Lizarraga AA, Kolb C, Eckert S, Weinstock-Guttman B, Zivadinov R. (2020) Disability Improvement Is Associated with Less Brain Atrophy Development in Multiple Sclerosis. AJNR. American journal of neuroradiology (Sep), 41(9): 1577-1583. doi:10.3174/ajnr.A6684
- Jakimovski D, Vaughn CB, Eckert S, Zivadinov R, Weinstock-Guttman B. (2020) Long-term drug treatment in multiple sclerosis: safety success and concerns. Expert opinion on drug safety (Sep), 19(9): 1121-1142.
- Ozel O, Vaughn CB, Eckert SP, Jakimovski D, Lizarraga AA, Weinstock-Guttman B. (2019) Dimethyl Fumarate in the Treatment of Relapsing-Remitting Multiple Sclerosis: Patient Reported Outcomes and Perspectives. Patient related outcome measures (Jan), 10: 373-384. doi:10.2147/PROM.S168095
- Weinstock-Guttman B, Eckert S, Benedict RH. (2018) A decline in cognitive function should lead to a change in disease-modifying therapy - Yes. Mult Scler (Nov), 24(13): 1681-1682.
- Abdollahpour I, Nedjat S, Mansournia MA, Eckert S, Weinstock-Guttman B. (2018) Stress-full life events and multiple sclerosis: A population-based incident case-control study. Mult Scler Relat Disord (Nov), 26: 168-172.
- Abdollahpour I, Nedjat S, Mansournia MA, Eckert S, Weinstock-Guttman B. (2018) Infectious exposure, antibiotic use, and multiple sclerosis: A population-based incident case-control study. Acta Neurol Scand (Oct), 138(4): 308-314.
- Cizza G, Primma S (Eckert S), Coyle M, Gourgiotis L, Csako G. (2010) Depression and osteoporosis: a research synthesis with meta-analysis. Horm Metab Res (Jun), 42(7): 467-482.
- Cizza G, Primma S (Eckert S), Csako G. (2009) Depression as a risk factor for osteoporosis. Trends Endocrinol Metab (Oct), 20(8): 367-373.
Professional Memberships:
- American Academy of Neurology; Professional society membership
- American Society of Neuroimaging; Professional society membership
Presentations:
- "Neurosurgery Grand Rounds on MS and NMOSD" Neurosurgery educational grand rounds (2020)
- "Emergency medicine grand rounds" Educations grand rounds on Neuroimaging (2019)
- "Invited Internal Medicine Morning Report" Interactive online teaching sessions to the internal medicine residents reviewing neuroimaging.
Service Activities:
- ; CPM preceptor (2020–present)